Activating mutations in PIK3CA are among the most common somatic point mutations in cancer, together with inactivation or loss of the tumour suppressor PTEN (a negative regulator of PI3K) (Chang et al., 2015; Sanchez-Vega et al., 2018; Campbell et al., 2020). The gene discussed is PIK3CA; the disease is cancer.